ZA9512B - Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene)cytidine - Google Patents
Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene)cytidineInfo
- Publication number
- ZA9512B ZA9512B ZA9512A ZA9512A ZA9512B ZA 9512 B ZA9512 B ZA 9512B ZA 9512 A ZA9512 A ZA 9512A ZA 9512 A ZA9512 A ZA 9512A ZA 9512 B ZA9512 B ZA 9512B
- Authority
- ZA
- South Africa
- Prior art keywords
- fluoromethylene
- cytidine
- deoxy
- monohydrate
- neoplastic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17895294A | 1994-01-07 | 1994-01-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9512B true ZA9512B (en) | 1995-09-11 |
Family
ID=22654587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9512A ZA9512B (en) | 1994-01-07 | 1995-01-03 | Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene)cytidine |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0738273B1 (xx) |
JP (1) | JPH09511227A (xx) |
KR (1) | KR100330328B1 (xx) |
CN (1) | CN1043231C (xx) |
AT (1) | ATE186732T1 (xx) |
AU (1) | AU684604B2 (xx) |
CA (1) | CA2179987C (xx) |
DE (1) | DE69421721T2 (xx) |
DK (1) | DK0738273T3 (xx) |
ES (1) | ES2141330T3 (xx) |
FI (1) | FI114396B (xx) |
GR (1) | GR3032614T3 (xx) |
HU (1) | HU217849B (xx) |
IL (1) | IL112242A (xx) |
MX (1) | MX9500363A (xx) |
NO (1) | NO306409B1 (xx) |
NZ (1) | NZ279030A (xx) |
TW (1) | TW397838B (xx) |
WO (1) | WO1995018815A1 (xx) |
ZA (1) | ZA9512B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130363C (zh) | 1997-11-12 | 2003-12-10 | 三菱化学株式会社 | 嘌呤衍生物以及含有其作为有效成分的药物 |
ATE254616T1 (de) | 1999-05-11 | 2003-12-15 | Mitsubishi Chem Corp | Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2002648C (en) * | 1988-11-15 | 2000-02-29 | James R. Mccarthy | 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
FI95269C (fi) * | 1989-05-15 | 1996-01-10 | Squibb Bristol Myers Co | 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja |
JPH0615557B2 (ja) * | 1990-02-19 | 1994-03-02 | ヤマサ醤油株式会社 | 2’―デオキシ―2’―メチリデンシチジンの2水和物結晶 |
KR100255258B1 (ko) * | 1992-05-12 | 2000-05-01 | 슈테펜 엘. 네스비트 | 리보뉴클레오티드 환원 효소 억제제의 제조방법 |
-
1994
- 1994-12-13 DE DE69421721T patent/DE69421721T2/de not_active Expired - Fee Related
- 1994-12-13 CA CA002179987A patent/CA2179987C/en not_active Expired - Fee Related
- 1994-12-13 DK DK95907232T patent/DK0738273T3/da active
- 1994-12-13 JP JP7518503A patent/JPH09511227A/ja active Pending
- 1994-12-13 HU HU9601848A patent/HU217849B/hu not_active IP Right Cessation
- 1994-12-13 AU AU15532/95A patent/AU684604B2/en not_active Ceased
- 1994-12-13 ES ES95907232T patent/ES2141330T3/es not_active Expired - Lifetime
- 1994-12-13 EP EP95907232A patent/EP0738273B1/en not_active Expired - Lifetime
- 1994-12-13 CN CN94194779A patent/CN1043231C/zh not_active Expired - Fee Related
- 1994-12-13 KR KR1019960703658A patent/KR100330328B1/ko not_active IP Right Cessation
- 1994-12-13 WO PCT/US1994/014648 patent/WO1995018815A1/en active IP Right Grant
- 1994-12-13 NZ NZ279030A patent/NZ279030A/en unknown
- 1994-12-13 AT AT95907232T patent/ATE186732T1/de not_active IP Right Cessation
-
1995
- 1995-01-03 ZA ZA9512A patent/ZA9512B/xx unknown
- 1995-01-04 IL IL11224295A patent/IL112242A/xx not_active IP Right Cessation
- 1995-01-04 TW TW084100012A patent/TW397838B/zh not_active IP Right Cessation
- 1995-01-06 MX MX9500363A patent/MX9500363A/es unknown
-
1996
- 1996-07-05 NO NO962848A patent/NO306409B1/no unknown
- 1996-07-05 FI FI962769A patent/FI114396B/fi active IP Right Grant
-
2000
- 2000-02-09 GR GR20000400313T patent/GR3032614T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI114396B (fi) | 2004-10-15 |
EP0738273A1 (en) | 1996-10-23 |
HUT75055A (en) | 1997-03-28 |
NO962848D0 (no) | 1996-07-05 |
IL112242A0 (en) | 1995-03-30 |
EP0738273B1 (en) | 1999-11-17 |
NZ279030A (en) | 1997-05-26 |
ES2141330T3 (es) | 2000-03-16 |
TW397838B (en) | 2000-07-11 |
NO306409B1 (no) | 1999-11-01 |
GR3032614T3 (en) | 2000-05-31 |
CN1141045A (zh) | 1997-01-22 |
CN1043231C (zh) | 1999-05-05 |
WO1995018815A1 (en) | 1995-07-13 |
KR100330328B1 (ko) | 2002-12-05 |
JPH09511227A (ja) | 1997-11-11 |
AU1553295A (en) | 1995-08-01 |
MX9500363A (es) | 1998-04-30 |
FI962769A0 (fi) | 1996-07-05 |
CA2179987C (en) | 1999-01-19 |
CA2179987A1 (en) | 1995-07-13 |
FI962769A (fi) | 1996-07-05 |
AU684604B2 (en) | 1997-12-18 |
DK0738273T3 (da) | 2000-04-17 |
HU9601848D0 (en) | 1996-09-30 |
DE69421721T2 (de) | 2000-04-27 |
ATE186732T1 (de) | 1999-12-15 |
HU217849B (hu) | 2000-04-28 |
DE69421721D1 (de) | 1999-12-23 |
IL112242A (en) | 2000-08-31 |
NO962848L (no) | 1996-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2288732B (en) | Pharmaceutical compositions | |
NO952228L (no) | Anvendelse av lamotrigin ved behandling av neurologiske lesjoner relatert til traumatiske skader | |
IL112539A (en) | Chloropyrimidine intermediates for preparing-2-aminopurine nucleoside analogues and their preparation | |
CA2002648A1 (en) | 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives | |
SE9500566L (sv) | L-platta | |
TR199701212T1 (xx) | �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�. | |
HU9503702D0 (en) | Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin | |
WO1996032403A3 (de) | Neue cytosin- und cytidinderivate | |
IE893080L (en) | Novel 2'-halomethylidene,2'-ethenylidene and¹2'-ethynyl adenosine derivatives | |
EP0347852A3 (en) | Novel neplanocin derivatives | |
DE69521122T2 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze | |
IL112242A (en) | Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene)cytidine | |
MY124071A (en) | Treatment of viral disease in swine | |
BR9811643A (pt) | Suplementação quìmica de osso | |
DE69836087D1 (de) | Kortikalknochenimplantat für wirbelfusion nach smith-robinson | |
GR3034688T3 (en) | Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions | |
GR3017335T3 (en) | Oligophosphates with antiviral activity. | |
BR0012380A (pt) | 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples | |
LTIP1943A (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
MY101613A (en) | Diabrotica larvicidal agents | |
IT1271291B (it) | La melatonina quale riequilibratore fisiologico del rapporto linfocitario th1/th2 | |
DE69407180T2 (de) | Fluoro-nukleosid-reinigung | |
ZA899510B (en) | 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition |